From: Conjugated linoleic acids as functional food: an insight into their health benefits
Treatment | Effect | Ref |
---|---|---|
CLA with creatine | CLA and creatine as adjuncts increased mictochondrial function by reducing sarcopenia and decreased oxidative stress in older adults | [116] |
CLA with ω-3 fatty acids | prevents increased abdominal fat and increases fat-free mass and adiponectin. | [28] |
9-CLA | No adverse effect on coronary vascular disease | [126] |
9-CLA | Modest anti-inflammatroy effect in allegic subjects | [32] |
CLA with γ-oryzanol | Reduced blood pressure and body fat. | [127] |
9-and 10-CLA | Enhanced fat oxidation and energy expenditure during sleep | [50] |
10-CLA | Anti-lipogenic effect in lactating women's mammary tissue | [128] |
CLA | Reduce weight gain induced by psychotropic medication | [129] |
CLA | Favourable effect on serum insulin, but no effect on body composition, energy expenditure of apetite. | [101] |
CLA | Increased resting metabolic rate, PPAR-γ and hormone-sensitive lipase | [68] |
CLA | No effect on glucose metabolism or insulin sensitivity on obese population. | [41] |
Trans fatty acids (t-11/t-12, 18:1) | Gender-based gene expression | [59] |
CLA | Inhibition on leptin, adiponection - contribute to insulin resistance | [26] |
CLA and Calcium | Reduces pregnancy-induced hypertension and decreases the intracellular concentration of ionised free calcium in peripheral blood lymphocytes. | [130] |
CLA | Do not beneficially change risk factors for cardiovascular disease or diabetes | [94] |
CLA and Vaccenic acid | No effect on blood pressure or arterial elasticity in healthy young men. | [131] |
CLA | Affect lipid and carbohydrate metabolism and reduced body weight | [27] |
CLA and other PUFA | Possible role in preventing renal carcinoma | [132] |
CLA | Reduce colorectal carcinoma | [133] |
CLA | Enhanced immunological function | |
CLA | Enhanced C-reactive protein | [43] |
CLA | Suppresses rheumatoid arthritis | [109] |
CLA | Lipid peroxidation | [124] |
CLA | Not good to treat metabolic syndrome | [134] |
CLA | Not associated with breast cancer | [76] |
10-CLA | Induces hyperproinsulinaemia, which predicts diabetes and cardiovascular disease | [124] |
CLA | Ptotective effect on the risk of metastasis in breast cancer | [75] |
10-CLA | Increases oxidative stress and inflammatroy biomarkers in obese men | [135] |
CLA | Positive impact on cardioprotective effect. | [89] |
CLA | Modulation of risk factor associated with atherosclerosis | [125] |